U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
192961192961Analysis of Genes Present in Cutaneous T-cell Lymphoma CellsCompletedNo Results AvailableLymphomaOther: laboratory biomarker analysishttps://ClinicalTrials.gov/show/NCT00020072
192962192962Docetaxel With or Without Thalidomide in Treating Patients With Metastatic Prostate CancerCompletedNo Results AvailableStage IV Prostate Cancer|Adenocarcinoma of the Prostate|Recurrent Prostate CancerDrug: docetaxel|Drug: thalidomidehttps://ClinicalTrials.gov/show/NCT00020046
192963192963Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By SurgeryCompletedNo Results AvailableLung Cancer|Metastatic CancerDrug: isolated perfusion|Drug: paclitaxel|Procedure: hyperthermia treatmenthttps://ClinicalTrials.gov/show/NCT00020007
192964192964Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: MART-1 antigen|Biological: aldesleukin|Biological: gp100 antigen|Biological: incomplete Freund's adjuvanthttps://ClinicalTrials.gov/show/NCT00019994
192965192965Isolated Limb Perfusion of Melphalan With or Without Tumor Necrosis Factor in Treating Patients With Soft Tissue Sarcoma of the Arm or LegCompletedNo Results AvailableStage IVB Adult Soft Tissue Sarcoma|Stage IIB Adult Soft Tissue Sarcoma|Stage IIC Adult Soft Tissue Sarcoma|Recurrent Adult Soft Tissue Sarcoma|Stage IVA Adult Soft Tissue Sarcoma|Stage III Adult Soft Tissue SarcomaDrug: melphalan|Drug: tumor necrosis factorhttps://ClinicalTrials.gov/show/NCT00019968
192966192966Radiofrequency Interstitial Tissue Ablation in Treating Patients With Localized Renal Cell Carcinoma (Kidney Cancer)CompletedNo Results AvailableKidney CancerProcedure: laparoscopic surgery|Procedure: radiofrequency ablation|Procedure: thermal ablation therapyhttps://ClinicalTrials.gov/show/NCT00019955
192967192967Vaccine Therapy in Treating Patients With Stage III Non-Small Cell Lung CancerCompletedNo Results AvailableLung CancerBiological: mutant p53 peptide pulsed dendritic cell vaccine|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00019929
192968192968Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian CancerCompletedNo Results AvailableBreast Cancer|Ovarian CancerBiological: aldesleukin|Biological: p53 peptide vaccine|Procedure: in vitro-treated peripheral blood stem cell transplantationhttps://ClinicalTrials.gov/show/NCT00019916
192969192969Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic MelanomaCompletedNo Results AvailableStage IV Melanoma|Stage III Melanoma|Recurrent MelanomaDrug: dendritic cell-gp100-MART-1 antigen vaccine|Drug: sargramostimhttps://ClinicalTrials.gov/show/NCT00019890
192970192970Combination Chemotherapy Before and After Surgery in Treating Patients With OsteosarcomaTerminatedNo Results AvailableCardiac Toxicity|SarcomaBiological: filgrastim|Drug: cisplatin|Drug: dexrazoxane hydrochloride|Drug: doxorubicin hydrochloride|Drug: leucovorin calcium|Drug: methotrexate|Procedure: adjuvant therapy|Procedure: conventional surgery|Procedure: neoadjuvant therapyhttps://ClinicalTrials.gov/show/NCT00019864
192971192971UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or LeukemiaCompletedNo Results AvailableLeukemia|LymphomaDrug: 7-hydroxystaurosporine|Drug: fludarabine phosphatehttps://ClinicalTrials.gov/show/NCT00019838
192972192972Decitabine in Treating Patients With Unresectable Lung or Esophageal Cancer or Malignant Mesothelioma of the PleuraCompletedNo Results AvailableEsophageal Cancer|Lung Cancer|Malignant Mesothelioma|Metastatic CancerDrug: decitabinehttps://ClinicalTrials.gov/show/NCT00019825
192973192973Monoclonal Antibody Plus Chemotherapy in Treating Patients With Metastatic Breast Cancer That Overexpresses HER2CompletedNo Results AvailableBreast CancerBiological: trastuzumab|Drug: paclitaxelhttps://ClinicalTrials.gov/show/NCT00019812
192974192974Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesCompletedNo Results AvailableColorectal Cancer|Islet Cell Tumor|Liver Cancer|Metastatic Cancer|Neuroendocrine CarcinomaDrug: isolated perfusion|Drug: melphalan|Procedure: conventional surgeryhttps://ClinicalTrials.gov/show/NCT00019786
192975192975Oxaliplatin Plus Capecitabine in Treating Patients With Colorectal, Appendix, or Small Bowel CancerCompletedNo Results AvailableCarcinoma of the Appendix|Colorectal Cancer|Small Intestine CancerDrug: capecitabine|Drug: oxaliplatinhttps://ClinicalTrials.gov/show/NCT00019773
192976192976Isolated Hepatic Perfusion With Melphalan Followed By Chemotherapy in Treating Patients With Unresectable Colorectal Cancer That is Metastatic to the LiverCompletedNo Results AvailableRecurrent Colon Cancer|Liver Metastases|Stage IV Rectal Cancer|Recurrent Rectal Cancer|Stage IV Colon CancerDrug: floxuridine|Drug: leucovorin calcium|Drug: melphalanhttps://ClinicalTrials.gov/show/NCT00019760
192977192977Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal CancerTerminatedHas ResultsColorectal CancerDrug: thalidomide|Procedure: adjuvant therapy|Other: Placebohttps://ClinicalTrials.gov/show/NCT00019747
192978192978Vaccine Therapy in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: fowlpox virus vaccine vector|Biological: vaccinia-tyrosinase vaccinehttps://ClinicalTrials.gov/show/NCT00019734
192979192979Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: MART-1 antigen|Biological: aldesleukin|Biological: gp100 antigen|Biological: incomplete Freund's adjuvanthttps://ClinicalTrials.gov/show/NCT00019721
192980192980Geldanamycin Analogue in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's LymphomaTerminatedNo Results AvailableExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Nodal Marginal Zone B-cell Lymphoma|Non-Hodgkin Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell LymphomaDrug: tanespimycinhttps://ClinicalTrials.gov/show/NCT00019708
192981192981Ketoconazole With or Without Alendronate Sodium in Treating Patients With Metastatic Prostate CancerTerminatedNo Results AvailableStage IV Prostate Cancer|Bone Metastases|Adenocarcinoma of the Prostate|Recurrent Prostate CancerDrug: alendronate sodium|Drug: ketoconazolehttps://ClinicalTrials.gov/show/NCT00019695
192982192982Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic MelanomaCompletedNo Results AvailableRecurrent Melanoma|Stage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin MelanomaBiological: Aldesleukin|Biological: gp100 Antigen|Drug: Montanide ISA 51 VG|Other: Quality-of-Life Assessment|Other: Questionnaire Administration|Other: Laboratory Biomarker Analysishttps://ClinicalTrials.gov/show/NCT00019682
192983192983Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic MelanomaCompletedNo Results AvailableMelanoma (Skin)Biological: aldesleukin|Biological: fowlpox virus vaccine vector|Biological: gp100 antigenhttps://ClinicalTrials.gov/show/NCT00019669
192984192984Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic CancerCompletedNo Results AvailableLeukemia|Lymphoma|Myelodysplastic Syndromes|Myelodysplastic/Myeloproliferative Neoplasms|Unspecified Adult Solid Tumor, Protocol SpecificDrug: perifosinehttps://ClinicalTrials.gov/show/NCT00019656
192985192985Factors Affecting Weight Gain in Women Receiving Adjuvant Chemotherapy for Breast CancerTerminatedNo Results AvailableDepression|Stage I Breast Cancer|Stage IIIA Breast Cancer|Nutrition|Stage II Breast Cancer|Psychosocial Effects/Treatment|Quality of Lifehttps://ClinicalTrials.gov/show/NCT00019643
192986192986Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNo Results AvailableChildhood Soft Tissue Sarcoma|Childhood Liver Cancer|Bone Cancer|Brain Tumor|Kidney TumorDrug: doxorubicin HCl liposomehttps://ClinicalTrials.gov/show/NCT00019630
192987192987Radiofrequency Ablation in Treating Patients With Unresectable Primary or Metastatic Liver CancerTerminatedHas ResultsLiver Cancer|Metastatic Cancer|Unspecified Adult Solid Tumor, Protocol SpecificProcedure: computed tomography|Procedure: magnetic resonance imaging|Procedure: positron emission tomography|Procedure: radiofrequency ablation|Procedure: radionuclide imaging|Procedure: ultrasound imaging|Radiation: fludeoxyglucose F 18 (FDG-PET)|Radiation: gadopentetate dimegluminehttps://ClinicalTrials.gov/show/NCT00019604
192988192988Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Locally Advanced or Metastatic Colorectal CancerCompletedNo Results AvailableColorectal CancerBiological: aldesleukin|Biological: ras peptide cancer vaccine|Procedure: adjuvant therapyhttps://ClinicalTrials.gov/show/NCT00019591
192989192989Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNo Results AvailableAdult Central Nervous System Germ Cell Tumor|Adult Malignant Meningioma|Adult Medulloblastoma|Adult Noninfiltrating Astrocytoma|Adult Oligodendroglioma|Adult Craniopharyngioma|Adult Meningioma|Brain Metastases|Adult Ependymoma|Adult Pineal Parenchymal TumProcedure: Sterotactic radiosurgeryhttps://ClinicalTrials.gov/show/NCT00019578
192990192990PET and/or MRI Scans in Assessing Tumor Response in Patients Receiving Antiangiogenesis TherapyCompletedNo Results AvailableUnspecified Adult Solid Tumor, Protocol SpecificProcedure: magnetic resonance imaging|Procedure: positron emission tomography|Radiation: fludeoxyglucose F 18https://ClinicalTrials.gov/show/NCT00019565

* Görseller ve İçerik tekif hakkına sahip olabilir